Doo‐Il Kim

4.5k citations
200 papers · 3.5k · 3 hit papers · h-index 31

Impact in

Papers in

    • Antiplatelet Therapy and Cardiovascular Diseases 19
    • Acute Myocardial Infarction Research 13
    • Cardiac electrophysiology and arrhythmias 11
    • Atrial Fibrillation Management and Outcomes 11
    • Coronary Interventions and Diagnostics 51
    • Cardiac Structural Anomalies and Repair 12

Doo‐Il Kim

183 papers receiving 3.4k citations

Doo‐Il Kim's Hit Papers

Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial 2025 · 43 citations
430+2+5Years since publication50100150200250

Peers

Doo‐Il Kim
Comparison fields: 5 of 137
  • Cardiology and Cardiovascular Medicine 1.2k
  • Internal Medicine 162
  • Surgery 973
  • Biotechnology 138
  • Pharmacology 130
Replace Alessandro Lupi with:
Alessandro Lupi Italy
In‐Suk Kim South Korea
Stefano de Franciscis Italy
Wojciech Witkiewicz Poland
Agata Magdalena Bielecka-Dabrowa Poland
Norbert Weiss Germany
Donald F. Brophy United States
Terezinha de Jesus Andreoli Pinto Brazil
Yu He China
Xiaozhong Guo China
Doo‐Il Kim relative to Alessandro Lupi Italy Alessandro Lupi's profile →
Citations per field
00.5×2×4×6.6×
Alessandro Lupi · 1×
Citations per year

Countries citing papers authored by Doo‐Il Kim

Since Specialization
Citations

This map shows the geographic impact of Doo‐Il Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doo‐Il Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doo‐Il Kim more than expected).

Fields of papers citing papers by Doo‐Il Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doo‐Il Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doo‐Il Kim. The network helps show where Doo‐Il Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside Doo‐Il Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Doo‐Il Kim Line = papers co-authored together Doo‐Il Kim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.

#Work
1
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
Hit paper breakdown →
2018275
2
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial
Hit paper breakdown →
2021264
3 2011242
4 2019159
5 2010140
6 2013117
7 201287
8 201379
9 201275
10 201175
11 200773
12 201364
13 201261
14 200960
15 201053
16 200747
17 201545
18 200544
19
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial
Hit paper breakdown →
202543
20 200841

About Doo‐Il Kim

Doo‐Il Kim is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 200 papers that have together received 3.5k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (51 papers), Antiplatelet Therapy and Cardiovascular Diseases (19 papers), Cardiac Imaging and Diagnostics (15 papers), Acute Myocardial Infarction Research (13 papers), Coronary Artery Anomalies (12 papers), Cardiac Structural Anomalies and Repair (12 papers), Cardiac electrophysiology and arrhythmias (11 papers) and Atrial Fibrillation Management and Outcomes (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.2k citations), Internal Medicine (162 citations), Surgery (973 citations), Biotechnology (138 citations) and Pharmacology (130 citations). Doo‐Il Kim has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Jae‐Gu Pan, Sang‐Hoon Seol, Dae-Kyeong Kim, Dong‐Soo Kim, Tae‐Hyun Yang, Dong‐Kie Kim, Jae‐Sik Jang, Han‐Young Jin, Taeho Ahn and Dong‐Hyun Kim. Their work appears in journals such as Circulation Journal, The American Journal of Cardiology, International Journal of Cardiology, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact